Carlyle's Revenue Forecasts Keep Falling but the Stock Refuses to Follow
The Carlyle Group Inc. (CG) reports second-quarter 2026 earnings tomorrow, August 5, before the market opens, with analysts expecting EPS of $0.88 on the heels of a modest miss last quarter. The central question: can this alternative asset manager reverse a recent trend of declining estimates and deliver results that justify its recent technical momentum, or will continued pressure on earnings growth send shares back toward their 200-day moving average? With the options market pricing a 7.52% expected move and analyst sentiment deteriorating, this report carries heightened stakes for a stock trading at $50.64.
Part 1: Earnings Preview
The Carlyle Group is a global alternative asset manager operating across three primary segments: Global Private Equity, Global Credit, and Global Investment Solutions, managing capital for institutional and individual investors worldwide. The firm's performance hinges on fundraising activity, portfolio company valuations, and fee-generating assets under management—all sensitive to market conditions and investor appetite for alternative investments.
Carlyle reports Q2 2026 earnings tomorrow morning with analysts expecting EPS of $0.88 on estimated revenue of $912 million. Last quarter, the company reported EPS of $0.89, missing the consensus estimate of $0.91 by 2.20%—its first earnings disappointment after three consecutive quarters of meeting estimates exactly. Year-over-year, the $0.88 estimate represents a -3.30% decline from the $0.91 reported in Q2 2025, reflecting headwinds facing the alternative asset management industry.
Three key themes define this earnings story:
Fundraising and Deployment Momentum: Investors will scrutinize Carlyle's ability to raise new capital and deploy existing dry powder in an environment where institutional investors have grown more selective. The pace of new fund commitments and the firm's success in putting capital to work directly impacts future fee streams and carried interest potential.
Portfolio Valuation Pressures: With public market volatility and rising interest rates affecting private company valuations, the mark-to-market performance of Carlyle's portfolio companies remains critical. Any writedowns or valuation adjustments could pressure distributable earnings and signal broader challenges in realizing returns.
Fee-Related Earnings Trajectory: As management fees provide the stable revenue base for alternative asset managers, analysts are watching whether Carlyle can grow fee-paying assets under management despite industry-wide fundraising challenges. The sustainability of fee-related earnings growth will determine the firm's ability to meet its full-year guidance of $3.71 per share.
Analyst commentary ahead of the release reflects caution, with estimates for the current quarter revised downward from $0.91 to $0.88 over recent months. However, analysts project a rebound in Q3 with EPS estimates of $1.08 (+10.20% growth), suggesting expectations that near-term headwinds may prove temporary if market conditions stabilize.
Part 2: Historical Earnings Performance
Carlyle's recent earnings history reveals a company that had achieved remarkable consistency before stumbling last quarter. Over the four quarters from Q2 2025 through Q1 2026, the firm met analyst estimates exactly in three consecutive quarters—reporting $0.91 in Q2 2025, $0.98 in Q3 2025, and $1.01 in Q4 2025—demonstrating an ability to manage expectations and deliver predictable results.
That pattern broke in Q1 2026 when Carlyle reported $0.89 against estimates of $0.91, a 2.20% miss that marked the company's first earnings disappointment in a year. While the magnitude of the miss was modest, it represented a meaningful shift from the prior trend of precision and raised questions about whether the firm's visibility into its quarterly performance had diminished or whether external pressures were mounting.
The sequential earnings progression also tells a story: after building momentum through the back half of 2025 (peaking at $1.01 in Q4), earnings declined sharply to $0.89 in Q1 2026—a 12% sequential drop that suggests seasonal factors or one-time headwinds may have impacted the quarter. With tomorrow's Q2 estimate of $0.88 implying further year-over-year decline, investors will be watching closely to determine whether this represents a temporary soft patch or the beginning of a more sustained earnings deceleration.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.91 | $0.91 | unch | Beat |
| Sep 2025 | $0.98 | $0.98 | unch | Beat |
| Dec 2025 | $1.01 | $1.01 | unch | Beat |
| Mar 2026 | $0.91 | $0.89 | -2.20% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Carlyle typically reports earnings before the market open, meaning Day 0 represents the first full trading session where investors can react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | -$1.79 (-3.52%) | $2.96 (5.83%) | +$1.62 (+3.31%) | $3.03 (6.18%) |
| 2026-02-06 | +$3.30 (+5.96%) | $3.81 (6.88%) | +$0.50 (+0.85%) | $1.63 (2.78%) |
| 2026-02-05 | -$2.98 (-5.10%) | $3.77 (6.47%) | +$3.30 (+5.96%) | $3.81 (6.88%) |
| 2025-11-07 | -$0.06 (-0.11%) | $2.80 (5.33%) | +$0.07 (+0.13%) | $1.51 (2.88%) |
| 2025-08-06 | +$2.80 (+4.66%) | $3.07 (5.11%) | -$1.33 (-2.11%) | $2.94 (4.67%) |
| 2025-08-05 | -$0.33 (-0.55%) | $1.63 (2.70%) | +$2.80 (+4.66%) | $3.07 (5.11%) |
| 2025-05-09 | +$0.78 (+1.89%) | $1.18 (2.86%) | +$3.58 (+8.52%) | $2.03 (4.83%) |
| 2025-05-08 | +$1.31 (+3.28%) | $1.58 (3.95%) | +$0.78 (+1.89%) | $1.18 (2.86%) |
| Avg Abs Move | 3.13% | 4.89% | 3.43% | 4.52% |
Historical price behavior around Carlyle's earnings releases shows significant volatility, with an average absolute Day 0 move of 3.13% and Day +1 move of 3.43%—both figures that suggest meaningful post-earnings reactions. The most recent earnings release on May 7, 2026, saw the stock decline 3.52% on Day 0 following the Q1 miss, then rebound 3.31% on Day +1, illustrating the two-way volatility that characterizes CG's earnings responses.
Looking at the broader pattern, Carlyle has experienced several dramatic post-earnings swings: the February 2026 reports produced a 5.96% Day 0 gain followed by a 5.10% decline the prior day, while the May 2025 release triggered an 8.52% Day +1 surge. The Day 0 range averages 4.89% while Day +1 averages 4.52%, indicating that initial reactions tend to be slightly more volatile than follow-through moves. Investors should prepare for a potential swing of 3-5% in either direction based on whether results and guidance exceed or disappoint expectations.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 17) |
| Expected Move | $3.81 (7.52%) |
| Expected Range | $46.83 to $54.45 |
| Implied Volatility | 52.61% |
The options market is pricing a 7.52% expected move through the August 21 expiration—substantially higher than Carlyle's average historical Day 0 move of 3.13% and even exceeding the average Day 0 range of 4.89%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction to tomorrow's results, possibly reflecting uncertainty around the earnings trajectory or expectations for significant guidance revisions that could drive outsized price action.
Part 3: What Analysts Are Saying
Analyst sentiment toward Carlyle has deteriorated heading into this earnings release, with the consensus recommendation standing at 3.89 (between Hold and Buy, closer to Hold). The analyst community is divided: 9 Strong Buys and 9 Holds create a split verdict, while 1 Moderate Sell adds a cautionary voice. Notably, the Hold camp expanded from 8 to 9 analysts over the past month, reflecting growing uncertainty about the stock's near-term prospects.
The average price target of $55.72 implies 10.0% upside from the current price of $50.64, suggesting analysts see value despite their mixed ratings. However, the wide range of targets—from a low of $44.00 to a high of $70.00—reveals significant disagreement about Carlyle's fair value. The low target implies 13.1% downside risk, while the high target suggests 38.2% upside potential, underscoring the divergent views on how the firm will navigate current industry headwinds.
The deterioration in sentiment appears tied to the downward revision in earnings estimates, with the current quarter's consensus falling from $0.91 to $0.88 and full-year 2026 estimates declining from $4.02 to $3.71. Despite near-term caution, analysts project a strong recovery in 2027 with EPS estimates of $5.18, representing 39.62% growth and suggesting the current weakness may be viewed as cyclical rather than structural.
Part 4: Technical Picture
The Barchart Technical Opinion for Carlyle has shifted dramatically in recent weeks, moving from an 88% Sell signal one month ago to a 40% Sell last week, and now registering just an 8% Sell currently. This rapid improvement in technical sentiment reflects the stock's strong recent momentum, with CG rallying from deeply oversold conditions to a more neutral technical posture heading into earnings.
Timeframe Analysis:
- Short-term (Hold): Neutral signal suggests the immediate trend has stabilized after recent gains, with momentum neither strongly positive nor negative
- Medium-term (50% Sell): Moderate sell signal indicates some lingering weakness in the intermediate timeframe despite recent improvement
- Long-term (Hold): Neutral reading reflects a balanced longer-term technical picture without clear directional bias
Trend Characteristics: The technical environment shows Minimum strength with a Weakening direction, suggesting the recent rally may lack conviction and could be vulnerable to reversal if earnings disappoint.
Carlyle's moving average structure reveals a stock in transition. Shares at $50.64 are trading above all short- and intermediate-term moving averages—the 5-day ($47.13), 10-day ($46.23), 20-day ($45.60), 50-day ($44.65), and 100-day ($46.54)—indicating strong recent momentum. However, the stock remains below its 200-day moving average of $51.67, a key long-term resistance level that has capped the recent rally.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $47.13 | 50-Day MA | $44.65 |
| 10-Day MA | $46.23 | 100-Day MA | $46.54 |
| 20-Day MA | $45.60 | 200-Day MA | $51.67 |
The technical setup heading into earnings is mixed: while short-term momentum is clearly positive with the stock breaking above all near-term moving averages, the failure to reclaim the 200-day average at $51.67 suggests bulls haven't yet established full control. The 200-day level represents critical resistance just 2.0% above current prices—a level that could be tested on a positive earnings surprise but might also act as a ceiling if results merely meet expectations. With the stock having rallied approximately 13% from its 50-day moving average in recent weeks, much of the good news may already be priced in, leaving CG vulnerable to profit-taking if the report fails to catalyze a breakout above that key long-term trend line.